Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/1998
06/13/1998CA2224025A1 Novel antibiotic, feglymycin, processes for its preparation and its use
06/11/1998WO1998024927A1 Compositions and methods for administering pneumococcal dna
06/11/1998WO1998024923A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998WO1998024911A2 Mutants of streptococcal toxin a and methods of use
06/11/1998WO1998024910A2 Mutants of streptococcal toxin c and methods of use
06/11/1998WO1998024905A2 Secreted proteins and polynucleotides encoding them
06/11/1998WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024782A2 Substituted pyrimidine compounds and their use
06/11/1998WO1998024763A2 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
06/11/1998WO1998024485A1 Inactivation of viruses by incubation with caprylate
06/11/1998WO1998024475A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
06/11/1998WO1998024460A1 Extracts of salvia species having antiviral activity
06/11/1998WO1998024397A2 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
06/11/1998WO1998016186A3 Monocyclic l-nucleosides, analogs and uses thereof
06/11/1998CA2274584A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274095A1 Compositions and methods for administering pneumococcal dna
06/11/1998CA2273924A1 Inactivation of viruses by incubation with caprylate
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2273822A1 Mutants of streptococcal toxin a and methods of use
06/11/1998CA2273199A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
06/11/1998CA2273192A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998CA2273002A1 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae
06/10/1998EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae
06/10/1998EP0846695A1 Process for the preparation of new intermediates useful in the synthesis of cephalosporins
06/10/1998EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same
06/10/1998EP0846110A1 Thf-containing sulfonamide inhibitors of aspartyl protease
06/10/1998EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection
06/10/1998EP0845992A1 Method of promoting angiogenesis
06/10/1998EP0845984A1 Use of aminoadamantane compounds as immunoregulators
06/10/1998EP0703725A4 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes
06/10/1998EP0675719B1 Novel combination of benzoquinazoline antifolates and protecting agents
06/10/1998EP0500699B1 Cross-protective salmonella vaccines
06/10/1998DE19644998C1 Verwendung von Adamantanaminen oder strukturanaloger Verbindungen zur Bekämpfung von Borna Disease Virus und zur Prophylaxe und Behandlung von Affekterkrankungen und anderen mit BDV-Infektionen verbundenen Störungen bei Mensch und Tier Use of adamantane structure or analogous compounds to combat Borna disease virus and for the prophylaxis and treatment of affective disorders and other disorders associated with BDV infections in humans and animals
06/10/1998CN1184531A Method for diagnosing a patient for chlamydia
06/10/1998CN1184505A Vaccines for plague
06/10/1998CN1184484A Novel anti-AIDS immunotoxins
06/10/1998CN1184483A Fucopeptides
06/10/1998CN1184481A Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
06/10/1998CN1184480A Esters of carbapenems
06/10/1998CN1184474A Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/10/1998CN1184473A 6- carboxamido dihydropyran derivatives
06/10/1998CN1184431A Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
06/10/1998CN1184427A 抗真菌组合物 Antifungal compositions
06/10/1998CN1184110A 1 -carba -(dethia) -cephalosporin derivatives
06/10/1998CN1184108A Anti-viral compounds
06/10/1998CN1183961A Liniment film for onychomycosis and its preparation technology
06/09/1998US5763631 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
06/09/1998US5763606 Coupling a silylated compound with a purine or pyrimidine base with a bicyclic intermediate and coupling with a lewis acid in solvent, reaction with reducing agent
06/09/1998US5763603 Crystalline tazobactam, and its production and use
06/09/1998US5763572 HTLV-II peptide antigens
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763472 Detection of microbes in water with kits having proteins
06/09/1998US5763454 Antibacterial agent
06/09/1998US5763450 Substituted benzyl pyrimidines
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763406 Method for the treatment of conditions caused by herpes virus infections
06/09/1998US5763397 Glycopeptides, a process for their preparation and their use
06/09/1998US5763395 Stable bactericidal mixtures for use in mouth washes or cosmetics
06/09/1998US5763268 Hepatitis delta virus compositions and expression vectors
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/09/1998US5763159 Hepatitis-C virus testing
06/09/1998US5762939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
06/09/1998US5762938 Modified recombinant vaccinia virus and expression vectors thereof
06/09/1998US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus
06/04/1998WO1998023771A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
06/04/1998WO1998023763A1 Heterologous antigens in live cell v. cholerae strains
06/04/1998WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/04/1998WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023637A1 Cyclohexapeptides having antimicrobial activity
06/04/1998WO1998023631A1 Novel bacterial polypeptides and polynucleotides
06/04/1998WO1998023627A1 Glycolipid mimics and methods of use thereof
06/04/1998WO1998023623A1 Carbapenem derivatives and antimicrobials
06/04/1998WO1998023622A1 Purification of fermented clavulanic acid
06/04/1998WO1998023621A1 Cephalosporin derivatives
06/04/1998WO1998009599A3 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
06/04/1998DE19647692A1 Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion Washing disinfectants for hygienic and surgical hand disinfection
06/04/1998CA2273021A1 Purification of fermented clavulanic acid
06/04/1998CA2272717A1 Cephalosporin derivatives
06/04/1998CA2244123A1 Carbapenem derivatives and antimicrobials
06/03/1998EP0845537A1 Recombinant retroviruses delivering vector constructs to target cells
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845530A2 Interferon gamma inducing factor
06/03/1998EP0845478A1 Reductive alkylation of glycopeptide antibiotics
06/03/1998EP0845476A2 Synthetic catalytic oligonucleotides
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0845001A1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
06/03/1998EP0844999A1 Purification process
06/03/1998EP0844878A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis c
06/03/1998EP0844877A1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
06/03/1998EP0844873A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
06/03/1998EP0509984B1 Method of preparing lysozyme dimers
06/03/1998CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183773A Alpha-substd. pyrimidine-thioalkyl and alkylether compounds
1 ... 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 ... 1798